The trademark Amatadin was filed by Olmosen ApS, a corporation established under the laws of the Kingdom of Denmark (the "Applicant"). The application was published for oppositions on May 19, 2021, and received one opposition filed on July 20, 2021 by TAD Pharma GmbH on Likelihood of confusion. the opponent was represented by UEXKÜLL & STOLBERG PARTNERSCHAFT VON PATENT- UND RECHTSANWÄLTEN MBB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued July 20, 2021
The application was filed in Danish, and Danish was also language of all opposition proceedings (English was selected as the second language).
Change of name and address of the trademark registration was recorded on March 14, 2022.